source
- STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart diseaseA Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.STAT · 2mo ago↗ source
- Opinion: The ‘brain drain’ narrative about health professionals misses half of the story52 health professionals returned home to 43 countries. Here are the unexpected challenges and opportunities they faced.STAT · 2mo ago↗ source
- Opinion: The cruise ship hantavirus outbreak is a warning sign to the U.S.Leaving the WHO means the U.S. lacks access to necessary information about infectious disease.STAT · 2mo ago↗ source